Panagiota Flevari

Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study

Markus Zabel, Rik Willems, Andrzej Lubiński et al. · European Heart Journal · 2020 · 154 citations · Full text

Medicine, Cardiology, Cardiothoracic Surgery +13

Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study

Konstantinos Gatzoulis, Dimitris Tsiachris, C. Antoniou et al. · European Heart Journal · 2019 · 139 citations · Full text

Medicine, Cardiology, Clinical Cardiology +16

Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study

George Theodorakis, Dionyssios Leftheriotis, Efthimios Livanis et al. · EP Europace · 2006 · 82 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries

Christian Sticherling, Barbora Arendacká, Jesper Hastrup Svendsen et al. · EP Europace · 2017 · 72 citations · Full text

Medicine, Cardiology, Cardiothoracic Surgery +13

Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study

Axel Bauer, Mathias Klemm, Konstantinos D. Rizas et al. · The Lancet · 2019 · 65 citations · Full text

Medicine, Cardiology, Preventive Cardiology +12